Three-year follow-up of visual outcome and quality of life in patients with age-related macular degeneration
Lena Rung,1 Monica Lövestam-Adrian21Department of Ophthalmology, Helsingborg Hospital, Helsingborg, 2Department of Ophthalmology, Lund University, Skåne University Hospital, Malmö, SwedenBackground: The purpose of this study was to evaluate the visual outcome...
Main Authors: | Rung L, Lövestam-Adrian M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-02-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/three-year-follow-up-of-visual-outcome-and-quality-of-life-in-patients-a12309 |
Similar Items
-
Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes
by: Razi F, et al.
Published: (2016-02-01) -
Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
by: Kaya A
Published: (2016-04-01) -
Changes in neurophysiologic markers of visual processing following beneficial anti-VEGF treatment in macular degeneration
by: Vottonen P, et al.
Published: (2013-02-01) -
Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-up
by: Cvetkova NP, et al.
Published: (2016-06-01) -
Long-Term Visual Outcomes for a Treat-and-Extend Antivascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration: Up to Seven-Year Follow-Up
by: Simon Javidi, et al.
Published: (2020-01-01)